Those with metabolic syndrome are twice at the risk of stroke if they sleep for less than 6 hours.
Highlights
- People with a common cluster of risk factors for heart disease and diabetes were approximately twice as likely to die of heart disease or stroke if they failed to get more than sixhours of sleep.
- The cluster included body mass index (BMI) higher than 30 and elevated total cholesterol, blood pressure, fasting blood sugar and triglyceride levels.
- Short sleepers with metabolic syndrome were also 1.99 times more likely to die from any cause compared to those without metabolic syndrome.
For this study, the cluster included body mass index (BMI) higher than 30 and elevated total cholesterol, blood pressure, fasting blood sugar and triglyceride levels.
During an average follow-up of 16.6 years, 22 percent of the participants died. Compared to people without the same cluster of risk factors, those with metabolic syndrome who clocked more than six hours of sleep time in the lab were about 1.49 times more likely to die of stroke during the 16.6-year follow-up period.
But those who slept less than six hours in the lab were about 2.1 times more likely to die of heart disease or stroke. The short sleepers with metabolic syndrome were also 1.99 times more likely to die from any cause compared to those without metabolic syndrome.
The relationship was particularly striking because the researchers adjusted for sleep apnea - sleep interrupted by pauses in breathing that is a known heart disease risk.
He noted that sleep lab studies are often used to rule out sleep apnea, but physicians should also note insufficient sleep in the lab because it may signal a higher risk of death in patients with risk factors for heart disease.
As the Fernandez-Mendoza research was an observational study, the results cannot establish a cause-and-effect, only an association between short sleep and mortality in people with the metabolic syndrome.
Additional limitations include that the study used only one day of sleep lab results and enrolled too few minority patients to determine whether there are racial differences in the relationship between short sleep times and mortality.
"Future clinical trials are needed to determine whether lengthening sleep, in combination with lowering blood pressure and glucose, improves the prognosis of people with the metabolic syndrome" said Fernandez-Mendoza.
Reference
- Julio Fernandez‐Mendoza et al., Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration, JAHA (2017) https:doi.org/10.1161/JAHA.117.005479.
Source-Medindia